ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Open Care announces Immubio platform based on nanoparticle science, currently developing potential break-through COVID-19 immunisation
December 18, 2020Open Care have announced the progress of their early-stage development of their potential COVID-19 Immunisation, ImmubioCV, based on Nanobiologics, a new approach centered on nanoparticles, water coherent domains and ultra dilutions that allows for the ..
Pharma Sources Insight January 2025
